Navigation Links
Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice
Date:5/22/2009

CORAL GABLES, Fla., May 22 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) today announced that on May 19, 2009 it was advised by The NASDAQ Stock Market(R) that, based on the Company's stockholders equity as reported in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2009, the Company is no longer in compliance with the $10 million minimum stockholders' equity requirement for continued listing on the NASDAQ Global Market under NASDAQ Marketplace Rule 5450(b)(1)(A). As of March 31, 2009, the Company's stockholders' equity was approximately $7.7 million. This notification has no immediate effect on the Company's listing on the NASDAQ Global Market or on the trading of the Company's common stock.

As provided in the rules of The NASDAQ Stock Market, the Company has until June 3, 2009 to provide The NASDAQ Stock Market with a plan to regain compliance with the NASDAQ Global Market continued listing requirements. If The NASDAQ Stock Market accepts the Company's plan, of which there can be no assurance, The NASDAQ Stock Market may grant the Company up to 105 days from May 19, 2009 to achieve and sustain compliance. If The NASDAQ Stock Market determines that the Company's plan is not sufficient to achieve and sustain compliance, it will provide written notice that the Company's common stock will be delisted from the NASDAQ Global Market. At such time, the Company may appeal NASDAQ's delisting determination to a NASDAQ Listing Qualifications Panel or may apply to list its common stock on the NASDAQ Capital Market. The NASDAQ Capital Market is a continuous trading market that operates in the same manner as the NASDAQ Global Market. All companies whose securities are listed on the NASDAQ Capital Market must meet certain financial requirements and adhere to NASDAQ's corporate governance standards.
'/>"/>

SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New fuel cell catalyst uses 2 metals
2. Fate Therapeutics and Stemgent Launch Catalyst: A Unique Industry Program for First Access to the Most Advanced Induced Pluripotent Stem Cell Technology
3. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
4. Researchers create catalysts for use in hydrogen storage materials
5. Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development
6. Brown chemists create more efficient palladium fuel cell catalysts
7. New catalyst paves the path for ethanol-powered fuel cells
8. Coalition for the Advancement of Medical Research Releases New White Paper, Catalyst for Cures: Embryonic Stem Cell Research
9. Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics
10. PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time
11. Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... and CHICAGO , June 3, 2015 ... "the Company"; LSE: CIR), a specialty biopharmaceutical company focused ... relating to the Company,s novel immunotherapy candidates targeting house ... at the 2015 European Academy of Allergy and Clinical ... Spain on 6-10 June. Sunday, ...
(Date:6/3/2015)... and CAMBRIDGE, Mass. and REYKJAVIK, Iceland ... , a precision medicine company using the genome to ... selected by Genomics England (GeL) to provide ... rare disease and cancer patients as part of the ... the UK National Health Service (NHS). ...
(Date:6/3/2015)... NC (PRWEB) June 03, 2015 ... the issuance of US Patent No. 9,044,273, underpinning ... improving the thoraco-lumbar spinal fusion implant procedure by ... them with one easy-to-use disposable instrument tray. The ... for numerous benefits over previous technology. Intelligent Implant ...
(Date:6/2/2015)... Global Stem Cells Group subsidiary Adimarket has been ... for the regeneration and repair of human organs and tissues. ... ambitious expansion plans in Latin America, a commitment made to ... and stem cell therapies. , Bioquark Inc. ... ability to alter the regulatory state of human tissues and ...
Breaking Biology Technology:Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3WuXi NextCODE Wins Genomics England Clinical Interpretation Tender in both Rare Disease and Cancer 2Intelligent Implant Systems Announces US Patent Attained for Revolution™ Spinal System 2Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 2Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 3
... announces that a new market research report is ... Anticoagulants Industry http://www.reportlinker.com/p098261/Global-Anticoagulants-Industry.html ... for Anticoagulants in US$ Million by the following ... Heparin, & Low Molecular Weight Heparin). The report ...
... 17, 2010 See video from Denmark at: ... The famous Danish astronomer Tycho Brahes, remains are ... National Museum in Prague, Czech Republic. On November ... in the coffin can be analyzed as the ...
... Nov. 17, 2010 Cell Therapeutics, Inc. ("CTI") (Nasdaq ... Agency ("EMA") approved CTI,s Pixuvri (pixantrone dimaleate) Pediatric Investigation ... solid tumors in children between the ages of six ... "PDCO") of the EMA adopted an opinion agreeing to ...
Cached Biology Technology:Reportlinker Adds Global Anticoagulants Industry 2Reportlinker Adds Global Anticoagulants Industry 3Reportlinker Adds Global Anticoagulants Industry 4Reportlinker Adds Global Anticoagulants Industry 5Reportlinker Adds Global Anticoagulants Industry 6Reportlinker Adds Global Anticoagulants Industry 7Reportlinker Adds Global Anticoagulants Industry 8Reportlinker Adds Global Anticoagulants Industry 9Reportlinker Adds Global Anticoagulants Industry 10Reportlinker Adds Global Anticoagulants Industry 11Reportlinker Adds Global Anticoagulants Industry 12Reportlinker Adds Global Anticoagulants Industry 13Reportlinker Adds Global Anticoagulants Industry 14Reportlinker Adds Global Anticoagulants Industry 15Reportlinker Adds Global Anticoagulants Industry 16Reportlinker Adds Global Anticoagulants Industry 17European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri 2European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri 3
(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
(Date:5/21/2015)... , May 21, 2015 The Sync ... of music for health, today announced a collaborative partnership ... The partnership will center on collaboration on original research, ... first step in the collaboration, The Sync Project and ... "Music as Medicine" in the 2015-2016 academic year.  ...
(Date:5/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... 3D-ID LLC, a company engaged in biometric identification is ... technology portion of the recently awarded TIES (Technical Information ... the Army. 3D-ID LLC has a suite ... enforcement and security agencies. Gino Pereira ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... , , , , , , ... IBM ( IBM ) and Fujitsu Frontech North America ... biometric technology from Fujitsu with IBM,s leading enterprise single sign-on solution. ... ) , The new offering aims to help companies bypass ...
... sediment cores is illuminating the environmental conditions that prevailed at ... Around 55 million years ago at the beginning of the ... free of ice. But by the early Oligocene around 25 ... had developed on Greenland. "This change from greenhouse ...
... Knowledge and Innovation Community (Climate-KIC)" is a major initiative the ... together the expertise of world class partners in a shared ... meet the climate change challenge in the years to come ... to this challenge, we need to bring about changes to ...
Cached Biology News:Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 2Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 3Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 4Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 5From greenhouse to icehouse -- reconstructing the environment of the Voring Plateau 2Innovation boost to tackle climate change 2Innovation boost to tackle climate change 3
Ly-49C and Ly-49I Biotin Anti-Mouse clone 5E6, Isotype Mouse IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Mouse monoclonal [M7-PB-E9] to pan alpha Sodium Potassium ATPase ( Abpromise for all tested applications)....
Gentamicin sulfate, 5g...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Biology Products: